It appears that your browser has JavaScript disabled.

This Website requires your browser to be JavaScript enabled.

Please enable JavaScript and reload this page.

polyvinyl-alcohol

65 Results Advanced Search

Site Content (20)

Can't Find What You're Looking For?

Contact Customer Service

Parteck® SRP 80 (Polyvinyl Alcohol) Excipient | Small Molecule Pharmaceuticals | Merck
Parteck® SRP 80, our new functional excipient based on polyvinyl alcohol (PVA), provides reliable sustained drug delivery over long release periods.
Polyvinyl Alcohol (PVA) for Drug Delivery | Small Molecule Pharmaceuticals | Merck
Our wide range of PVA types allow us to support you in finding the PVA grade with just the right properties for your specific formulation needs.
Press Release: Merck Introduces Parteck® SRP 80 Excipient for Sustained-Release Oral Solid Dose Formulations
Parteck® SRP 80 is a polyvinyl alcohol (PVA) based excipient specifically designed for modified-release applications, for optimization of pharmacokinetics and pharmacodynamics as well as the bioavailability of actives.
Parteck® COAT (Polyvinyl Alcohol) Excipient | Small Molecule Pharmaceuticals | Merck
Parteck® COAT (Polyvinyl Alcohol) Excipient Reduce coating time with optimized particle properties.
Bioavailability Enhancement | Small Molecule Pharmaceuticals | Merck
Merck boosts your productivity by enhancing bioavailability with a wide range of products.
Bioavailability Enhancement | Biopharmaceutical Manufacturing | Merck
Merck boosts your productivity by enhancing bioavailability with a wide range of products.
Press Release: Merck Collaborates with Kuraray to Improve Drug Delivery
Merck today announced it has extended and expanded its collaboration with Kuraray Europe to exclusively supply pharmaceutical polyvinyl alcohol (PVA) grades and improvements to benefit the pharmaceutical market.
Parteck® MXP | Merck
Our new Parteck® MXP is specifically designed for application in HME. The polyvinyl alcohol-based excipient enhances the solubility of a wide range of APIs with low solubility.
Parteck® MXP Excipient for Hot Melt Extrusion | Small Molecule Pharmaceuticals | Merck
Our new Parteck® MXP is a polyvinyl alcohol-based excipient for hot melt extrusion to increase solubility and allow for stable and high drug loads for a broad range of APIs.
Press Release: Merck Launches Parteck® MXP Excipient for Increased Solubility
Merck today introduced Parteck® MXP, a polyvinyl alcohol-based excipient that enhances solubility of a wide range of active pharmaceutical ingredients (APIs) with poor bioavailability.